Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5-Aminolevulinate and 4, 5-dioxovalerate ions decrease GABA(A) receptor density in neuronal cells, synaptosomes and

Avishek Adhikari1, Carlos A A Penatti, Rodrigo R Resende

  • 1Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Av. Prof. Lineu Prestes 748, 05508-900 São Paulo, SP, Brazil.

Brain Research
|May 17, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Fungal Bioluminescent Pathway (FBP)-Based Yeast Biosensor for Caffeic Acid Quantification in Food and Beverages.

ACS sensors·2026
Same author

Purinergic-cytokine signaling as a regulatory axis in neuroimmune development.

Neuropharmacology·2026
Same author

The Flavonoid Rutin Enhances Temozolomide Sensitivity in Glioblastoma Spheroids by Modulating Chemoresistance via PI3K/AKT, STAT3, Redox and Kynurenine Pathways, and Altering ECM Remodeling Associated with Reduced Migration.

Antioxidants (Basel, Switzerland)·2026
Same author

Caffeylpyruvate hydrolase from the bioluminescent fungus Neonothopanus gardneri is the key recycling enzyme in the fungal bioluminescence pathway.

The FEBS journal·2026
Same author

Uncovering Spatiotemporal and Functional Dynamics of Long Non-coding RNAs During Alzheimer's Progression in the Human Brain at Single-Cell Resolution.

Molecular neurobiology·2026
Same author

Methodological guidelines for P2X receptor assays and data interpretation.

Cell death & disease·2026

5-aminolevulinate (ALA) and its oxidation product 4,5-dioxovalerate (DOVA) damage GABA(A) receptors. This damage may explain neurological symptoms in porphyria and lead poisoning.

Area of Science:

  • Neuroscience
  • Metabolic Disorders
  • Toxicology

Background:

  • Porphyrias, like intermittent acute porphyria (IAP) and lead poisoning, involve 5-aminolevulinate (ALA) accumulation.
  • ALA's central nervous system (CNS) effects are linked to GABA(A) receptor damage, potentially caused by oxyradicals and 4,5-dioxovalerate (DOVA) from ALA oxidation.

Purpose of the Study:

  • To investigate the impact of ALA and DOVA on GABA(A) receptor density.
  • To explore the role of ALA and DOVA in the neurological manifestations of porphyrias.

Main Methods:

  • In vitro studies using synaptosomes and neuronal cells (P19, WERI) exposed to ALA and DOVA.
  • In vivo studies involving ALA or succinylacetone methyl ester (SAME) treatment in rats.
  • Radiolabeling assays and immunohistochemistry to quantify GABA(A) receptor density.

Related Experiment Videos

Main Results:

  • DOVA exposure decreased synaptosomal GABAergic sites by approximately 50%.
  • DOVA altered P19 and WERI cell morphology and decreased GABA(A) receptor density, increasing WERI cell mortality.
  • ALA treatment reduced GABA(A) receptor density and altered neuronal morphology in P19 cells.
  • ALA and SAME treatments reduced GABAergic receptor density in specific rat brain regions (habenular complex, parabigeminal nucleus).

Conclusions:

  • ALA and DOVA promote damage to GABA(A) receptors.
  • This receptor damage likely contributes to the neurological symptoms observed in IAP and lead poisoning.